drugset / Trial / NCT03530319

Treatment of Macrolide-resistant Mycoplasma Pneumoniae

NCT03530319

RandomizedParallel-groupOpen-labelTreatment

Summary

A randomized clinical trial comparing treatment effectiveness of azithromycin and doxycycline for pediatric Mycoplasma pneumonia.

Timeline

Start
2018-11-10
Primary completion
2021-12-31
Completion
2021-12-31

Drugs

EvaluationDrugModalityDoseRoute
Comparator Azithromycin Small molecule 10 mg/kg
Subject Doxycycline Small molecule 2 mg/kg Oral
Subject Doxycycline Small molecule 4 mg/kg Oral